Comments
Loading...

Soleno Therapeutics

SLNONASDAQ
Logo brought to you by Benzinga Data
$53.55
0.631.19%
At Close: -
$54.07
0.520.97%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$93.00
Lowest Price Target1
$40.00
Consensus Price Target1
$67.14

Soleno Therapeutics (NASDAQ:SLNO) Stock, Analyst Ratings, Price Targets, Forecasts

Soleno Therapeutics Inc has a consensus price target of $67.14 based on the ratings of 7 analysts. The high is $93 issued by Piper Sandler on February 5, 2024. The low is $40 issued by Guggenheim on November 21, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Oppenheimer, and Cantor Fitzgerald on September 3, 2024, August 12, 2024, and July 31, 2024, respectively. With an average price target of $67.33 between HC Wainwright & Co., Oppenheimer, and Cantor Fitzgerald, there's an implied 24.53% upside for Soleno Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
May
1
Jul
1
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Oppenheimer
Cantor Fitzgerald
Baird
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Soleno Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Soleno Therapeutics (SLNO) stock?

A

The latest price target for Soleno Therapeutics (NASDAQ:SLNO) was reported by HC Wainwright & Co. on September 3, 2024. The analyst firm set a price target for $70.00 expecting SLNO to rise to within 12 months (a possible 29.46% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Soleno Therapeutics (SLNO)?

A

The latest analyst rating for Soleno Therapeutics (NASDAQ:SLNO) was provided by HC Wainwright & Co., and Soleno Therapeutics initiated their buy rating.

Q

When was the last upgrade for Soleno Therapeutics (SLNO)?

A

There is no last upgrade for Soleno Therapeutics

Q

When was the last downgrade for Soleno Therapeutics (SLNO)?

A

There is no last downgrade for Soleno Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Soleno Therapeutics (SLNO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Soleno Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Soleno Therapeutics was filed on September 3, 2024 so you should expect the next rating to be made available sometime around September 3, 2025.

Q

Is the Analyst Rating Soleno Therapeutics (SLNO) correct?

A

While ratings are subjective and will change, the latest Soleno Therapeutics (SLNO) rating was a initiated with a price target of $0.00 to $70.00. The current price Soleno Therapeutics (SLNO) is trading at is $54.07, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch